AI can produce fluent healthcare content quickly. Fluency and clinical reliability are not the same property, and patients cannot tell them apart.
The failure mode is confidence
AI-drafted patient content rarely fails by sounding wrong. It fails by sounding certain — stating a dosage range without its condition, compressing a nuanced risk into a reassurance, or generalizing guidance that only applies to a subgroup.
Because the prose reads well, these drafts often bypass the scrutiny a rougher human draft would attract. Governance has to be deliberate rather than incidental.
A review protocol worth adopting
Organizations using AI in patient-facing workflows benefit from a written protocol applied consistently, regardless of who prompted the draft.
- Every clinical claim verified against a named current source
- Every instruction checked for the conditions and exceptions it omits
- Reading level and comprehension assessed independently of accuracy
- A named clinical reviewer recorded, with the date of review
- Nothing published from a draft whose source material cannot be identified
Human review is the deliverable
The value of AI in healthcare communication is speed to a first draft. The value an organization must supply is judgment — and it must be able to show that judgment was applied.
Documented human clinical review turns AI from an unmanaged risk into a defensible part of the content process.
Used carefully, AI shortens the path to good patient materials. Used without review, it shortens the path to publishing something no clinician would have signed.
Related advisory service: Healthcare AI Content Review